April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Anterior Vitrectomy vs Triamcinolone Assisted Vitrectomy
Author Affiliations & Notes
  • Jose Alberto Nava
    Instituto de Oftalmologia - Catarata, Centro Medico Zambrano Hellion - Tec de Monterrey, San Pedro Garza Garcia, Mexico
  • Footnotes
    Commercial Relationships Jose Nava, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2298. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jose Alberto Nava; Anterior Vitrectomy vs Triamcinolone Assisted Vitrectomy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2298.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To compare the postoperative results in patients who had Anterior Vitrectomy (VAS) vs Triamcinolone Assisted Vitrectomy (VAT) in an ophthalmology training center.

Methods: Cataract surgery cases with vitreous loss from an ophthalmology training center were randomly injected with air and triamcinolone suspension (40 mg/ml). A maximum dose of 4mg/0.1ml was injected into the anterior chamber to visualize the vitreous. The anterior chamber was refilled with BBS and anterior vitrectomy was performed. Postoperative results were compared

Results: 24 cases with vitreous loss were evaluated. VAT vs VAS results were: residual vitreous strands to the wound VAT(0) / VAS(8); intraocular pressure > 25 mmHg VAT(3) / VAS(3); corneal edema VAT(0) / VAS(6); Retinal detachment VAT(0) / VAS(1).

Conclusions: The use of triamcinolone during anterior vitrectomy improved visualization of vitreous and reduced postoperative inflammation

Keywords: 445 cataract • 737 training/teaching cataract surgery  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.